surrounding area pain had persisted, especially with movement and daily activities, such as showering, dressing, brushing/blow-drying hair, reaching, applying vehicle seatbelt, etc; frozen shoulder/adhesive capsulitis; arm soreness/ My arm is still sore; Pain in the shoulder/right shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness/ My arm is still sore), PERIARTHRITIS (frozen shoulder/adhesive capsulitis), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (surrounding area pain had persisted, especially with movement and daily activities, such as showering, dressing, brushing/blow-drying hair, reaching, applying vehicle seatbelt, etc) and ARTHRALGIA (Pain in the shoulder/right shoulder pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pneumonia (Route: IM, body site: deltoid, Dose number in series: 1of1) on 24-Mar-2021, tetanus (Route: IM, body site: deltoid and Dose number in series: 1of1) on 24-Mar-2021. Past adverse reactions to the above products included No adverse event with pneumonia and tetanus. Concurrent medical conditions included Muscle cramps and Ache. Concomitant products included POTASSIUM GLUCONATE from 07-Apr-2021 to an unknown date and MAGNESIUM OXIDE from 07-Apr-2021 to an unknown date for Muscle cramps and Ache.    On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced ARTHRALGIA (Pain in the shoulder/right shoulder pain). On 13-May-2021, the patient experienced PAIN IN EXTREMITY (arm soreness/ My arm is still sore). On 29-Sep-2021, the patient experienced PERIARTHRITIS (frozen shoulder/adhesive capsulitis). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (surrounding area pain had persisted, especially with movement and daily activities, such as showering, dressing, brushing/blow-drying hair, reaching, applying vehicle seatbelt, etc). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and DICLOFENAC SODIUM (VOLTAREN [DICLOFENAC SODIUM]) (topical) for Frozen shoulder, at a dose of 2g to right shoulder up to 4 times daily as needed. At the time of the report, PAIN IN EXTREMITY (arm soreness/ My arm is still sore) and ARTHRALGIA (Pain in the shoulder/right shoulder pain) had not resolved and PERIARTHRITIS (frozen shoulder/adhesive capsulitis) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (surrounding area pain had persisted, especially with movement and daily activities, such as showering, dressing, brushing/blow-drying hair, reaching, applying vehicle seatbelt, etc) outcome was unknown.            The patient had typical upper arm discomfort after first dose that resolved with massage and movement of arm within a few days. The patient kept the arm active and massaged the area, but the pain persisted. The patient used massage, heat and ibuprofen, with minor degree of temporary relief.   On 29-Sep-2021, the patient was evaluated by my primary medical doctor for this condition. No imaging was performed. Her PMD (primary medical doctor) suspected adhesive capsulitis/"frozen shoulder" and prescribed diclofenac sodium (Voltaren) 1% gel 2g to right shoulder up to 4 times daily as needed and physical therapy. The patient was using the topical gel as prescribed, without relief of right shoulder and surrounding area pain. Physical therapy had been scheduled and was pending. Her arm was still sore even after months. The pain in the shoulder never went away.   This case was linked to MOD-2021-304599 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Oct-2021: Follow-up information included historical vaccine, concomitant, treatment medication and new events.; Sender's Comments: This case concerns a 62-year-old female patient with no relevant medical history, who experienced the unexpected event of Periarthritis and expected event of Arthralgia. The event Arthralgia occurred on the same day after the second dose of mRNA-1273 (Moderna COVID-19 Vaccine) while the event Periarthritis occurred 140 days after the second dose. The rechallenge was unknown since it was not disclosed if the event resolved after the first dose. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.